Aerovate Therapeutics Inc (AVTE)
20.46
+0.63
(+3.18%)
USD |
NASDAQ |
May 13, 09:40
Aerovate Therapeutics Total Assets (Quarterly): 127.42M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.42M |
| September 30, 2023 | 140.88M |
| June 30, 2023 | 155.76M |
| March 31, 2023 | 124.39M |
| December 31, 2022 | 135.30M |
| September 30, 2022 | 147.66M |
| June 30, 2022 | 155.68M |
| Date | Value |
|---|---|
| March 31, 2022 | 167.00M |
| December 31, 2021 | 175.36M |
| September 30, 2021 | 184.12M |
| June 30, 2021 | 62.43M |
| March 31, 2021 | 9.948M |
| December 31, 2020 | 4.715M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.715M
Minimum
Dec 2020
184.12M
Maximum
Sep 2021
122.36M
Average
140.88M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Insmed Inc | 1.159B |
| Annexon Inc | 297.67M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.96M |
| Shareholders Equity (Quarterly) | 109.46M |